US2005064513A1PendingUtilityA1
High throughput functional proteomics
Priority: Jul 13, 2001Filed: Jul 29, 2004Published: Mar 24, 2005
Est. expiryJul 13, 2021(expired)· nominal 20-yr term from priority
G01N 33/6848Y10T436/24G01N 33/66Y10T436/255Y10T436/25375
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method is disclosed which provides a high throughput method for assigning plausible functions to unknown sequence entries in a particular database. The method was used herein to identify lectin proteins which can be found in specific tissues of the rice plant.
Claims
exact text as granted — not AI-modified1 - 9 . (Canceled)
10 . A method of ascribing a function to a protein, said method comprising:
(a) providing a composition comprising one or more proteins; (b) applying said composition to a functional affinity column; (c) eluting a bound protein from said functional affinity column; (d) preparing said eluted protein for mass spectrometry; (e) analyzing at least a portion of said eluted protein by mass spectrometry thereby producing spectral information; (f) identifying said eluted protein by matching said spectral information with a theoretical mass spectrum of a protein having a known sequence; and (g) ascribing a function to said identified protein based on the affinity chromatographic behavior of said identified protein.
11 . The method of claim 10 , wherein preparing said eluted protein for mass spectrometry comprises subjecting said eluted protein to proteolysis and one or more dimensional chromatography.
12 . The method of claim 11 , wherein said one or more dimensional chromatography is performed using a high performance liquid chromatography column comprising a strong anion exchange resin followed by a reverse phase resin.
13 . The method of claim 10 , wherein said composition is a protein extract.
14 . The method of claim 13 , wherein said protein extract is from a tissue or cell.
15 . The method of claim 14 , wherein said cell is a microbe.
16 . The method of claim 14 , wherein said cell is a parasite.
17 . The method of claim 14 , wherein said cell is a cancer cell.
18 . The method of claim 13 , wherein said protein extract is fractionated prior to application to said functional affinity column.
19 . The method of claim 10 , wherein said functional affinity column comprises a small molecule.
20 . The method of claim 19 , wherein said small molecule is a pharmacophore.
21 . (Canceled)
22 . The method of claim 10 , wherein said functional affinity column comprises a ligand selected from the group consisting of ATP, phosphate, ECM, metal ion, and enzymatic domain.
23 . (Canceled)
24 . The method of claim 10 , wherein said bound protein is eluted from said functional affinity column in a single step.
25 . The method of claim 10 , wherein said bound protein is eluted from said functional affinity column using a stepwise or continuous gradient.
26 . The method of claim 10 , wherein said mass spectrometry is tandem mass spectrometry.
27 . The method of claim 10 , wherein the sequence of said protein having a known sequence is present in a database.
28 . The method of claim 27 , wherein the sequence of said protein having a known sequence is derived from a nucleic acid.
29 . The method of claim 27 , wherein said protein having a known sequence has an unidentified function.
30 - 31 . (Canceled)
32 . A method of ascribing a function to a protein, said method comprising:
(a) providing a composition comprising one or more proteins; (b) applying said composition to a functional affinity column comprising a ligand, wherein said ligand is a peptide or protein domain; (c) eluting a bound protein from said functional affinity column; (d) preparing said eluted protein for mass spectrometry; (e) analyzing at least a portion of said eluted protein by mass spectrometry thereby producing spectral information; (f) identifying said eluted protein by matching said spectral information with a theoretical mass spectrum of a protein having a known sequence; and (g) ascribing a function to said identified protein based on the functional affinity chromatographic behavior of said identified protein.
33 . The method of claim 32 , wherein preparing said eluted protein for mass spectrometry comprises subjecting said eluted protein to proteolysis and one or more dimensional chromatography.
34 . The method of claim 33 , wherein said one or more dimensional chromatography is performed using a high performance liquid chromatography column comprising a strong anion exchange resin followed by a reverse phase resin.
35 . The method of claim 32 , wherein said composition is a protein extract.
36 . The method of claim 35 , wherein said protein extract is from a tissue or cell.
37 . The method of claim 36 , wherein said cell is a microbe.
38 . The method of claim 36 , wherein said cell is a parasite.
39 . The method of claim 36 , wherein said cell is a cancer cell.
40 . The method of claim 35 , wherein said protein extract is fractionated prior to application to said functional affinity column.
41 . The method of claim 32 , wherein said ligand is a cell surface peptide.
42 . The method of claim 32 , wherein said bound protein is eluted from said functional affinity column in a single step.
43 . The method of claim 32 , wherein said bound protein is eluted from said functional affinity column using a stepwise or continuous gradient.
44 . The method of claim 32 , wherein said mass spectrometry is tandem mass spectrometry.
45 . The method of claim 32 , wherein the sequence of said protein having a known sequence is present in a database.
46 . The method of claim 45 , wherein the sequence of said protein having a known sequence is derived from a nucleic acid.
47 . The method of claim 45 , wherein said protein having a known sequence has an unidentified function.Join the waitlist — get patent alerts
Track US2005064513A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.